Top 10 Stocks in Focus on Tuesday, 17 January 2017
Here is a list of 10 stocks that are likely to remain in focus on Monday in response to various news triggers:
Reliance Industries: Reliance Industries on Monday reported a 3.6 per cent rise in its third quarter net profit after a dip in refinery margins was offset by robust petrochemical earnings. Consolidated net profit of Rs 7,506 crore in October-December quarter, was 3.6 per cent higher than Rs 7,245 crore in the same period quarter a year ago.
Tata Global Beverages: The company would exit from its Chinese JV Zhejiang Tata Tea Extraction Co Ltd (ZTTECL).
Bharat Petroleum Corporation Ltd: The oil marketing company on Monday informed bourses that it has received in-principle approval of merger of Petronet CCK Ltd. (PCCKL) with itself.
Infosys: Infosys on Monday announced its internal carbon price at $10.5 per tonne of CO2e, at an event organised by the Carbon Pricing Leadership Coalition (CPLC) in Zurich. A significant milestone for Infosys, the price will be applicable for a period of two years and will represent the cost of decarbonizing 1 tonne of CO2e.
Teamlease Services: The company has signed a definite agreement to acquire 100 per cent shares in Keystone Business Solutions. The consideration involved in the transaction is Rs 8.2 crore payable in cash.
Delta Corp: The company has received a licence for operations of a casino in Gangtok, Sikkim.
Cairn India: For Q3 FY2017, average gross production across assets was resilient at 181,818 barrels of oil equivalent per day (boepd). As expected, the production was lower primarily due to planned maintenance shutdown in Rajasthan and natural decline in offshore assets.
Hindustan Zinc: In line with company’s on-going expansion to reach 1.2 mtpa mined metal production capacity, environmental clearances were received for Sindesar Khurd expansion of ore production capacity from 3.75 mtpa to 4.5 mtpa for Zawar mine to 4 mtpa.
Fortis Healthcare: Daiichi Sankyo has moved an application in Delhi High Court to block former Ranbaxy Lab promoters Malvinder and Shivinder Singh from
selling their stake in Fortis Healthcare, marking a new twist in the Rs 2,500 crore arbitration case.
Titan Company: The company has decided to consolidate its portfolio by migrating the Gold Plus network to become part of the Tanishq network.